RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on stubborn head and neck cancers enters human testing
Disease control Recruiting nowThis early-phase trial is for people with head and neck cancer that has persisted or returned after prior treatment. It combines an immunotherapy drug (pembrolizumab) with radiation therapy before and during surgery to see if this approach is safe and can kill more cancer cells. …
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:33 UTC
-
Experimental drug combo aims to boost standard cancer treatment
Disease control Recruiting nowThis early-stage trial tests the safety and best dose of the drug decitabine when given alongside standard treatments (surgery, radiation, and/or chemotherapy) for people with a type of head and neck cancer that is not caused by HPV and can be surgically removed. The goal is to s…
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New drug cocktail aims to shrink head and neck tumors before surgery
Disease control Recruiting nowThis study is testing whether giving two drugs (lucanoximab and tagolimab) before surgery can help shrink tumors in people with head and neck cancer. About 30 adults with resectable cancer will receive the drugs intravenously every two weeks for two cycles, then undergo surgery. …
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug shows promise in shrinking head and neck tumors before surgery
Disease control Recruiting nowThis study tests a drug called ivonescimab given before surgery for people with stage II to IV head and neck cancer that can be removed. The drug helps the immune system attack cancer cells. The goal is to see if it can shrink tumors and improve treatment results. About 28 adults…
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:48 UTC